IndraLab

Statements


BRAF binds KRAS and mtnN. 1 / 1
| 1

sparser
"The same analysis in the total group of cetuximab-treated patients showed a significant association of the KRAS (HR 1.3; p = 0.044 for PFS and HR 1.5; p = 0.0065 for OS) and BRAF (HR 2.0; p = 0[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"